DrugsControl Media Services

News Detail

NPPA directs Novartis to continue production of pain reliever Voltaflam 50 mg (18-09-2021)

New Delhi, 18 Sept 2021: The National Pharmaceutical Pricing Authority (NPPA) has directed Novartis India to maintain normal production, distribution and availability of its pain relieving medicine Voltaflam 50 mg in the market, even though the company applied to discontinue the ......
View Details

Source : Pharmabiz

Related News